APM
Aptorum Group Ltd Class A
NASDAQ: APM · HEALTHCARE · BIOTECHNOLOGY
$0.89
+1.48% today
Updated 2026-04-29
Market cap
$7.25M
P/E ratio
—
P/S ratio
23.35x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Aptorum Group Ltd Class A (APM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.76M | $-5.78M | $-10.04M | $-13.38M | $-15.93M | $-14.65M | $-12.32M | $-7.72M | $-1.19M | $-1.84M |
| Capital expenditures | $2.09M | $3.06M | $6.06M | $1.11M | $161314.00 | $137776.00 | $186916.00 | $3010.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $1.61M | $1.48M | $1.68M | $1.65M | $1.27M | $0.00 | $0.00 |
| Free cash flow | $-4.85M | $-8.84M | $-16.10M | $-14.49M | $-16.09M | $-14.79M | $-12.51M | $-7.73M | $-1.19M | $-1.84M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $51881.00 | — | — | — | $755514.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |